Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
about
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST.Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters.Drug interactions in childhood cancer.Drug-drug interactions with imatinib: An observational study.Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?Interactions between oral antineoplastic agents and concomitant medication: a systematic review.Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia.Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects.Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.Clinical efficacy of generic imatinibManaging Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner
P2860
Q34048307-4DC582CC-AEB7-4779-8CC2-406D9C658177Q34071827-FA615610-8EBD-4B8C-BF53-D52FF98B3B50Q36898141-0891A079-768D-4237-AB1F-0C8FB596BB62Q37328934-731EACA7-66CF-4739-A256-0AB5C44EF3DEQ37862942-99C78331-7482-4C2A-A774-EDC8DD8603BFQ38022125-17A79CEE-0191-4E55-BC62-59E3F6103BD6Q38099040-B7630873-D7B8-4577-B953-B1CAAC0B1AF2Q40721053-572115E8-F3AE-449A-8572-86BFD9665CE4Q41404243-C28744C9-5D4C-4E06-8D30-3B1072BFEFB5Q41763725-85AECD93-74AD-4F2F-9B4F-67A51A5BB6F4Q43841175-C2054CE2-8E47-4516-AC41-AFD5D2C64A7EQ47161255-6E89F0A5-948B-4949-B760-82B1315811FDQ47969048-28120C93-1016-4324-AFAA-79CE1F068567Q51337867-095E4648-5B0B-4699-886E-A8BC2B305E9AQ55060584-D64A1735-7D4B-432E-B2D0-26E6F5A1F6BAQ57108016-9AA5CCB3-61E3-4CFE-B0CE-AC119CD9203CQ57498748-1E0F6C63-D408-405D-9BD2-0E24C811ADF1
P2860
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@en
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@nl
type
label
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@en
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@nl
prefLabel
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@en
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@nl
P2093
P2860
P1476
Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
@en
P2093
Brian M Miller
Dhvani D Shah
Kristin A Komazec
Mara A Yerk
Merrill J Egorin
Robert L Redner
Susan M Christner
P2860
P304
P356
10.1111/J.1365-2125.2009.03466.X
P407
P577
2009-09-01T00:00:00Z